semaglutide approval date The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Semaglutide: First Global Approval |

People may also have higher insulin levels, altered gut bacteria, genetic predispositions, or other barriers to losing weight

She reviews your medical history, current medications, and any health conditions that may be contributing to weight challenges including thyroid dysfunction, insulin resistance, hormonal imbalances, and sleep disorders

Clinical trials have shown that tirzepatide (Mounjaro, Zepbound) generally leads to greater weight loss compared to semaglutide (Ozempic, Wegovy)

Your medical team will closely track your progress, adjust your treatment plan as needed, and provide ongoing support throughout your weight loss journey

Tell your health care provider about your medical history prior to taking Compounded Liraglutide